Effect of binary combinations of solvent systems on permeability profiling of pure agomelatine across rat skin: a comparative study with statistically optimized polymeric nanoparticles

References

• National Institute of Mental Health. Depression; 2018. Available from: https://www.nimh.nih.gov/health/topics/depression/index.shtml
   Google Scholar
• Marcus M, Yasamy MT, Van Ommeren M, et al. Depression: a global public health concern, WHO Department of Mental Health and Substance Abuse; 2012. p. 1–4. Available from: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf
   Google Scholar
• Dubovsky SL, Warren C. Agomelatine, a melatonin agonist with antidepressant properties. Expert Opin Investig Drugs. 2009;18(10):1533–1540.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34(1):119–138.
   PubMed Web of Science ®Google Scholar
• Alvano SA, Zieher LM. An updated classification of antidepressants: a proposal to simplify treatment. Personal Med Psychiatry. 2020;19–20:100042.
   Google Scholar
• Kennedy SH. Agomelatine: efficacy at each phase of antidepressant treatment. CNS Drugs. 2009;23(Suppl. 2):41–47.
   PubMed Web of Science ®Google Scholar
• Dolder CR, Nelson M, Snider M. Agomelatine treatment of major depressive disorder. Ann Pharmacother. 2008;42(12):1822–1831.
   PubMed Web of Science ®Google Scholar
• Buoli M, Mauri MC, Altamura AC. Pharmacokinetic evaluation of agomelatine for the treatment of generalized anxiety disorder. Expert Opin Drug Metab Toxicol. 2014;10(6):885–892.
   PubMed Web of Science ®Google Scholar
• de Bodinat C, Guardiola-Lemaitre B, Mocaër E, et al. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9(8):628–642.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K. Agomelatine: a narrative review. Eur Neuropsychopharmacol. 2011;21:S703–S709.
   PubMed Web of Science ®Google Scholar
• Bali NR, Salve PS. Selegiline nanoparticle embedded transdermal film: an alternative approach for brain targeting in Parkinson’s disease. J Drug Deliv Sci Technol. 2019;54:101299.
   Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 2015;22(8):1059–1070.
   PubMed Web of Science ®Google Scholar
• Imam SS, Ahad A, Aqil M, et al. Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal. Mater Sci Eng C. 2017;75:1198–1205.
   PubMed Web of Science ®Google Scholar
• Ansari MD, Ahmed S, Imam SS, et al. CCD based development and characterization of nano-transethosome to augment the antidepressant effect of agomelatine on Swiss albino mice. J Drug Deliv Sci Technol. 2019;54:101234.
   Web of Science ®Google Scholar
• Alkilani A, McCrudden MT, Donnelly R. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470.
   PubMed Web of Science ®Google Scholar
• Kunst A, Lee G. Release and skin permeation of scopolamine from thin polymer films in relation to thermodynamic activity. J Pharm Sci. 2016;105(4):1496–1500.
   PubMed Web of Science ®Google Scholar
• Rambharose S, Kalhapure RS, Jadhav M, et al. Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers. Drug Deliv Transl Res. 2017;7(2):333–345.
   PubMed Web of Science ®Google Scholar
• Twist JN, Zatz JL. Membrane–solvent–solute interaction in a model permeation system. J Pharm Sci. 1988;77(6):536–540.
   PubMed Web of Science ®Google Scholar
• Tomoda K, Makino K. Nanoparticles for transdermal drug delivery system (TDDS). In: Hiroyuki Ohshima, Kimiko Makino, editors. Colloid and interface science in pharmaceutical research and development. UK: Elsevier; 2014. p. 131–147.
   Google Scholar
• Jana U, Mohanty AK, Pal SL, et al. Felodipine loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo toxicity study. Nano Convergence. 2014;1(1):10.
   PubMedGoogle Scholar
• Fatouh AM, Elshafeey AH, Abdelbary A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des Dev Ther. 2017;11:1815–1825.
   PubMed Web of Science ®Google Scholar
• Karemore MN, Avari JG. Zeta potential as a novel diagnostic tool for preeclampsia. Pregnancy Hypertens. 2018;13:187–197.
   PubMed Web of Science ®Google Scholar
• Vijayan V, Reddy KR, Sakthivel S, et al. Optimization and characterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies. Colloids Surf B. 2013;111:150–155.
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Patel JR. Transdermal delivery of azidothymidine (AZT) through rat skin ex vivo. Pharm Sci. 1997;3:83–87.
   Google Scholar
• Narishetty STK, Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release. 2004;95(3):367–379.
   PubMed Web of Science ®Google Scholar
• Uchechi O, Ogbonna JDN, Attama AA. 2014. Nanoparticles for dermal and transdermal drug delivery, application of nanotechnology in drug delivery. In: Sezer AD, editor. IntechOpen. Available from: https://www.intechopen.com/books/application-of-nanotechnology-in-drug-delivery/nanoparticles-for-dermal-and-transdermal-drug-delivery
   Google Scholar
• Singh R Jr., Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223.
   PubMed Web of Science ®Google Scholar
• Mura S, Hillaireau H, Nicolas J, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine. 2011;6:2591–2605.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329–347.
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14(11):1568–1573.
   PubMed Web of Science ®Google Scholar
• Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release. 2001;70(3):353–363.
   PubMed Web of Science ®Google Scholar
• Couvreur P, Barratt G, Fattal E, et al. Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst. 2002;19(2):99–134. [PubMed: 12197610]
   PubMed Web of Science ®Google Scholar
• Ansary RH, Awang MD, Rahman MM. Biodegradable poly(d,l-lactic-co-glycolic acid) based micro/nanoparticles for sustained release of protein drugs – a review. Trop J Pharm Res. 2014;13(7):1179–1190.
   Web of Science ®Google Scholar
• Fluhr JW, Lazzerini S, Distante F, et al. Effects of prolonged occlusion on stratum corneum barrier function and water holding capacity. Skin Pharmacol Physiol. 1999;12(4):193–198.
   Web of Science ®Google Scholar
• Tang H, Blankschtein D, Langer R. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway. J Pharm Sci. 2002;91(8):1891–1907.
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Salve PS, Thomas NS, et al. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 2001;219(1–2):95–105.
   PubMed Web of Science ®Google Scholar
• Barry BW. Properties that influence percutaneous absorption. In: Barry BW, editor. Dermatological formulations. New York: Marcel Dekker; 1983. p. 127–233.
   Google Scholar
• Holegaard A, Mollgaard B. Dermal drug delivery—improvement by choice of vehicle or drug derivative. J Control Release. 1985;2:111–120.
   Google Scholar
• Naves L, Dhand D, Almeida L, et al. Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Prog Biomater. 2017;6(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Hersh DS, Wadajkar AS, Roberts N, et al. Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharm Des. 2016;22(9):1177–1193.
   PubMed Web of Science ®Google Scholar
• Bali NR, Shinde M, Rathod S, et al. Enhanced transdermal permeation of rasagiline mesylate nanoparticles: design, optimization, and effect of binary combinations of solvent systems across biological membrane. Int J Polym Mater Polym Biomater. 2020.
   PubMed Web of Science ®Google Scholar
• Ostrenga J, Steinmetz C, Poulsen B, et al. Significance of vehicle composition: II. Prediction of optimal vehicle composition. J Pharm Sci. 1971;60(8):1180–1183.
   PubMed Web of Science ®Google Scholar
• Thomas NS, Panchagnula R. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur J Pharm Sci. 2003;18(1):71–79.
   PubMed Web of Science ®Google Scholar
• Bommannan D, Potts RO, Guy RH. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release. 1991;16(3):299–304.
   Web of Science ®Google Scholar
• Harrison JE, Watkinson AC, Green DM, et al. The relative effect of azone and transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm Res. 1996;13(4):542–546.
   PubMed Web of Science ®Google Scholar